ESALF
Price
$30.75
Change
-$1.25 (-3.91%)
Updated
Aug 26 closing price
Capitalization
8.79B
KHTRF
Price
$4.72
Change
-$0.00 (-0.00%)
Updated
Aug 27 closing price
Capitalization
460.99M
Interact to see
Advertisement

ESALF vs KHTRF

Header iconESALF vs KHTRF Comparison
Open Charts ESALF vs KHTRFBanner chart's image
Eisai
Price$30.75
Change-$1.25 (-3.91%)
Volume$300
Capitalization8.79B
Knight Therapeutics
Price$4.72
Change-$0.00 (-0.00%)
Volume$800
Capitalization460.99M
ESALF vs KHTRF Comparison Chart in %
Loading...
ESALF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KHTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ESALF vs. KHTRF commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESALF is a StrongBuy and KHTRF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ESALF: $30.75 vs. KHTRF: $4.72)
Brand notoriety: ESALF and KHTRF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ESALF: 10% vs. KHTRF: 15%
Market capitalization -- ESALF: $8.79B vs. KHTRF: $460.99M
ESALF [@Pharmaceuticals: Generic] is valued at $8.79B. KHTRF’s [@Pharmaceuticals: Generic] market capitalization is $460.99M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESALF’s FA Score shows that 2 FA rating(s) are green whileKHTRF’s FA Score has 0 green FA rating(s).

  • ESALF’s FA Score: 2 green, 3 red.
  • KHTRF’s FA Score: 0 green, 5 red.
According to our system of comparison, ESALF is a better buy in the long-term than KHTRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESALF’s TA Score shows that 5 TA indicator(s) are bullish while KHTRF’s TA Score has 3 bullish TA indicator(s).

  • ESALF’s TA Score: 5 bullish, 5 bearish.
  • KHTRF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both ESALF and KHTRF are a bad buy in the short-term.

Price Growth

ESALF (@Pharmaceuticals: Generic) experienced а -4.47% price change this week, while KHTRF (@Pharmaceuticals: Generic) price change was +1.29% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.00%. For the same industry, the average monthly price growth was +11.42%, and the average quarterly price growth was +84.24%.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.00% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESALF($8.79B) has a higher market cap than KHTRF($461M). KHTRF has higher P/E ratio than ESALF: KHTRF (62.66) vs ESALF (27.69). KHTRF YTD gains are higher at: 30.748 vs. ESALF (19.696). ESALF has higher annual earnings (EBITDA): 104B vs. KHTRF (52M). ESALF has more cash in the bank: 266B vs. KHTRF (116M). KHTRF has less debt than ESALF: KHTRF (105M) vs ESALF (188B). ESALF has higher revenues than KHTRF: ESALF (789B) vs KHTRF (385M).
ESALFKHTRFESALF / KHTRF
Capitalization8.79B461M1,908%
EBITDA104B52M200,000%
Gain YTD19.69630.74864%
P/E Ratio27.6962.6644%
Revenue789B385M204,935%
Total Cash266B116M229,310%
Total Debt188B105M179,048%
FUNDAMENTALS RATINGS
ESALF vs KHTRF: Fundamental Ratings
ESALF
KHTRF
OUTLOOK RATING
1..100
9447
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
72
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
691
PRICE GROWTH RATING
1..100
4947
P/E GROWTH RATING
1..100
9597
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ESALF's Valuation (10) in the null industry is somewhat better than the same rating for KHTRF (72). This means that ESALF’s stock grew somewhat faster than KHTRF’s over the last 12 months.

ESALF's Profit vs Risk Rating (100) in the null industry is in the same range as KHTRF (100). This means that ESALF’s stock grew similarly to KHTRF’s over the last 12 months.

ESALF's SMR Rating (6) in the null industry is significantly better than the same rating for KHTRF (91). This means that ESALF’s stock grew significantly faster than KHTRF’s over the last 12 months.

KHTRF's Price Growth Rating (47) in the null industry is in the same range as ESALF (49). This means that KHTRF’s stock grew similarly to ESALF’s over the last 12 months.

ESALF's P/E Growth Rating (95) in the null industry is in the same range as KHTRF (97). This means that ESALF’s stock grew similarly to KHTRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ESALFKHTRF
RSI
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
43%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
39%
Momentum
ODDS (%)
Bearish Trend 2 days ago
72%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
47%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
35%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
44%
Bullish Trend 2 days ago
39%
Advances
ODDS (%)
Bullish Trend 28 days ago
38%
Bullish Trend 3 days ago
41%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
53%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
42%
View a ticker or compare two or three
Interact to see
Advertisement
ESALF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KHTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TRPA39.07N/A
+0.01%
Hartford AAA CLO ETF
FDTS53.13N/A
N/A
First Trust DevMkts exUS SC AlphaDEX®ETF
VETZ19.92N/A
N/A
Academy Veteran Impact ETF
BSTZ21.80-0.05
-0.23%
BlackRock Science and Technology Term Trust
AGGH20.60-0.05
-0.24%
Simplify Aggregate Bond ETF

ESALF and

Correlation & Price change

A.I.dvisor tells us that ESALF and ESAIY have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESALF and ESAIY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESALF
1D Price
Change %
ESALF100%
N/A
ESAIY - ESALF
26%
Poorly correlated
-0.64%
DVAX - ESALF
23%
Poorly correlated
-1.72%
KHTRF - ESALF
22%
Poorly correlated
N/A
SHPH - ESALF
22%
Poorly correlated
-2.20%
BLMH - ESALF
21%
Poorly correlated
-3.91%
More

KHTRF and

Correlation & Price change

A.I.dvisor tells us that KHTRF and PLSH have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KHTRF and PLSH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KHTRF
1D Price
Change %
KHTRF100%
N/A
PLSH - KHTRF
25%
Poorly correlated
N/A
OVATF - KHTRF
24%
Poorly correlated
N/A
BHC - KHTRF
23%
Poorly correlated
+1.39%
ORGO - KHTRF
22%
Poorly correlated
+0.41%
ESALF - KHTRF
21%
Poorly correlated
N/A
More